| abstract |
A process is provided for preparing chiral diol sulfones of the structure n n nwhere R 3 is preferably n n nwhere R 4a is preferably aryl such as phenyl, and R 1a is preferably alkyl such as t-butyl, which are intermediates used in preparing HMG CoA reductase inhibitors. |